Article Details

Noxopharm in-licenses novel RNA tech for drug discovery and vaccines - BioPharma Reporter

Retrieved on: 2021-12-06 17:02:37

Tags for this article:

Click the tags to see associated articles and topics

Noxopharm in-licenses novel RNA tech for drug discovery and vaccines - BioPharma Reporter. View article details on HISWAI: https://www.biopharma-reporter.com/Article/2021/12/06/Noxopharm-in-licenses-novel-RNA-tech-for-drug-discovery-and-vaccines

Excerpt

Pharmorage will first target mRNA vaccines: eying up a market expected to reach $23bn USD by 2035. One of its goals will be to target unwanted side- ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up